(Q35620731)

English

Angiotensin receptor blockers as anti-hypertensive treatment for patients with diabetes mellitus: meta-analysis of controlled double-blind randomized trials

scientific article published on January 2004

In more languages

Statements

scholarly article

1 reference

Europe PubMed Central

PubMed publication ID

9 August 2017

0 references

1 reference

Europe PubMed Central

Angiotensin receptor blockers as anti-hypertensive treatment for patients with diabetes mellitus: meta-analysis of controlled double-blind randomized trials (English)

1 reference

Europe PubMed Central

PubMed publication ID

9 August 2017

1 reference

based on heuristic

inferred from title

author name string

Siebenhofer A

1

1 reference

Europe PubMed Central

PubMed publication ID

9 August 2017

Plank J

2

1 reference

Europe PubMed Central

PubMed publication ID

9 August 2017

Horvath K

3

1 reference

Europe PubMed Central

PubMed publication ID

9 August 2017

Berghold A

4

1 reference

Europe PubMed Central

PubMed publication ID

9 August 2017

Sutton AJ

5

1 reference

Europe PubMed Central

PubMed publication ID

9 August 2017

Sommer R

6

1 reference

Europe PubMed Central

PubMed publication ID

9 August 2017

Pieber TR

7

1 reference

Europe PubMed Central

PubMed publication ID

9 August 2017

language of work or name

1 reference

based on heuristic

inferred from title

publication date

1 January 2004

1 reference

Europe PubMed Central

PubMed publication ID

9 August 2017

Diabetic Medicine

1 reference

Europe PubMed Central

PubMed publication ID

9 August 2017

21

1 reference

Europe PubMed Central

PubMed publication ID

9 August 2017

1

1 reference

Europe PubMed Central

PubMed publication ID

9 August 2017

18-25

1 reference

Europe PubMed Central

PubMed publication ID

9 August 2017

Tight blood pressure control and risk of macrovascular and microvascular complications in type 2 diabetes: UKPDS 38. UK Prospective Diabetes Study Group

1 reference

https://api.crossref.org/works/10.1111%2FJ.1464-5491.2004.01122.X

21 January 2018

Risks of untreated and treated isolated systolic hypertension in the elderly: meta-analysis of outcome trials

1 reference

https://api.crossref.org/works/10.1111%2FJ.1464-5491.2004.01122.X

21 January 2018

The role of the renin-angiotensin system in the development of cardiovascular disease

1 reference

https://api.crossref.org/works/10.1111%2FJ.1464-5491.2004.01122.X

21 January 2018

The effect of irbesartan on the development of diabetic nephropathy in patients with type 2 diabetes

1 reference

https://api.crossref.org/works/10.1111%2FJ.1464-5491.2004.01122.X

21 January 2018

Renoprotective effect of the angiotensin-receptor antagonist irbesartan in patients with nephropathy due to type 2 diabetes

1 reference

https://api.crossref.org/works/10.1111%2FJ.1464-5491.2004.01122.X

21 January 2018

Effects of losartan on renal and cardiovascular outcomes in patients with type 2 diabetes and nephropathy

1 reference

https://api.crossref.org/works/10.1111%2FJ.1464-5491.2004.01122.X

21 January 2018

Cardiovascular morbidity and mortality in patients with diabetes in the Losartan Intervention For Endpoint reduction in hypertension study (LIFE): a randomised trial against atenolol

1 reference

https://api.crossref.org/works/10.1111%2FJ.1464-5491.2004.01122.X

21 January 2018

Angiotensin II type 1 receptor blockers

1 reference

https://api.crossref.org/works/10.1111%2FJ.1464-5491.2004.01122.X

21 January 2018

Improving the quality of reports of meta-analyses of randomised controlled trials: the QUOROM statement. Quality of Reporting of Meta-analyses

1 reference

https://api.crossref.org/works/10.1111%2FJ.1464-5491.2004.01122.X

21 January 2018

Assessing the quality of reports of randomized clinical trials: is blinding necessary?

1 reference

https://api.crossref.org/works/10.1111%2FJ.1464-5491.2004.01122.X

21 January 2018

Meta-analysis in clinical trials

1 reference

https://api.crossref.org/works/10.1111%2FJ.1464-5491.2004.01122.X

21 January 2018

Cardiovascular morbidity and mortality in the Losartan Intervention For Endpoint reduction in hypertension study (LIFE): a randomised trial against atenolol

1 reference

https://api.crossref.org/works/10.1111%2FJ.1464-5491.2004.01122.X

21 January 2018

Comparison of candesartan, enalapril, and their combination in congestive heart failure: randomized evaluation of strategies for left ventricular dysfunction (RESOLVD) pilot study. The RESOLVD Pilot Study Investigators

1 reference

https://api.crossref.org/works/10.1111%2FJ.1464-5491.2004.01122.X

21 January 2018

Effect of losartan compared with captopril on mortality in patients with symptomatic heart failure: randomised trial--the Losartan Heart Failure Survival Study ELITE II.

1 reference

https://api.crossref.org/works/10.1111%2FJ.1464-5491.2004.01122.X

21 January 2018

A randomized trial of the angiotensin-receptor blocker valsartan in chronic heart failure

1 reference

https://api.crossref.org/works/10.1111%2FJ.1464-5491.2004.01122.X

21 January 2018

Effects of losartan and captopril on mortality and morbidity in high-risk patients after acute myocardial infarction: the OPTIMAAL randomised trial. Optimal Trial in Myocardial Infarction with Angiotensin II Antagonist Losartan

1 reference

https://api.crossref.org/works/10.1111%2FJ.1464-5491.2004.01122.X

21 January 2018

The effects of losartan and fosinopril in hypertensive type 2 diabetic patients

1 reference

https://api.crossref.org/works/10.1111%2FJ.1464-5491.2004.01122.X

21 January 2018

Effects of low-dose losartan treatment on persistent microalbuminuria in normotensive type 1 diabetic subjects

1 reference

https://api.crossref.org/works/10.1111%2FJ.1464-5491.2004.01122.X

21 January 2018

Are β-Blockers Efficacious as First-line Therapy for Hypertension in the Elderly?

1 reference

https://api.crossref.org/works/10.1111%2FJ.1464-5491.2004.01122.X

21 January 2018

Identifiers

10.1111/J.1464-5491.2004.01122.X

1 reference

Europe PubMed Central

PubMed publication ID

9 August 2017

PubMed publication ID

1 reference

Europe PubMed Central

PubMed publication ID

9 August 2017

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q35620731&oldid=1861499038"